Key result
Mastering underlying arrhythmia pathophysiology remains essential for guiding effective antiarrhythmic drug therapy.
Why the study?
A comprehensive understanding of the mechanisms of cardiac arrhythmias and antiarrhythmic drug actions is needed to improve therapy strategies.
A review emphasizing the need to master the complex pathophysiology of arrhythmias to improve pharmacologic and device-based therapies.
Answers are grounded in this paper and cite their sources.
Review of antiarrhythmic mechanisms leaves open refined therapeutic strategies; hypothesis-generating for future targeted trials.
The purpose of this review is to consider our understanding of the mechanisms of action of cardiac antiarrhythmic drugs, as well as the status of our comprehension of arrhythmias and their therapy. The approach will be to review the basis for normal electric activity of the heart, the mechanisms for cardiac arrhythmias, and our understanding of the mechanisms of drug action, and to distill from these strategies for the future. Immediate strategies in the prevention and treatment of life-threatening arrhythmias will most likely continue to make use of catheter and electrically based therapy, but the longterm treatment of large populations of individuals will still require the search for, and testing and administration of, pharmacologic therapy. It is emphasized that simplistic approaches to the solution of the complex problem of arrhythmias and their management of probably continue to cause problems, and that only by mastering the complexities of pathophysiology may success be best assured.
No takes yet. Share an insight, caveat, or question.
Michael R. Rosen (1995) conducted a review in Cardiac arrhythmias. Cardiac antiarrhythmic drugs was evaluated. A review of cardiac antiarrhythmic drugs emphasizes that mastering the complexities of pathophysiology is essential for the successful management of arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: